Target intelligence / Profile preview

CD8-positive T cell infiltration and activation (null)

Target
null
Molecular classification
Other (cellular process; involves multiple molecular families such as receptors [e.g., T cell receptor, CD28], integrins, cytokine receptors, chemokine receptors)
01

Overview

The phrase "CD8+ T cell infiltration/activation" refers to the multi-step immunological process where CD8-positive cytotoxic T lymphocytes migrate from the bloodstream into tissues such as tumors, followed by activation through three main signals: antigen recognition by the T cell receptor (TCR), co-stimulatory signals (primarily via CD28), and cytokine signaling. This activation results in effector functions such as direct killing of infected or malignant cells, secretion of cytokines, and orchestration of broader immune responses. The presence and activity of CD8+ T cells within tumors is a key determinant of effective anti-tumor immunity and is predictive of response to immunotherapy[1][3][4][5]. Mechanisms regulating this process include adhesion and integrin interactions for infiltration, three-signal paradigms for activation, and checkpoints (PD-1, CTLA-4, etc.) that limit overactivation and maintain self-tolerance[1][4].

Other names
CD8+ T cell responseCD8+ T cell recruitment and activationcytotoxic T lymphocyte (CTL) infiltration/activation
02

Mechanism of action

Enhancement of T cell activation, inhibition of co-inhibitory receptors (e.g., anti-PD-1/PD-L1, anti-CTLA-4), stimulation with cytokines, adoptive transfer of activated T cells

03

Biological functions

Immune responsecell-mediated cytotoxicityadaptive immunitycancer immunityinfection control
04

Disease associations

Cancer (tumor infiltration predicts response to immunotherapy)infectionchronic inflammationautoimmunity
05

Safety considerations

Autoimmunitycytokine release syndromeoff-target tissue damageimmune-related adverse events
06

Interacting drugs

Immune checkpoint inhibitors (e.g., pembrolizumab, nivolumab)

2 more in the full profile.

07

Biomarkers

Tumor-infiltrating CD8+ T cell densityPD-1/PD-L1 expressionIFN-γ expressiongranzyme Bperforin levels

Beyond the preview

Go deeper on CD8-positive T cell infiltration and activation (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CD8-positive T cell infiltration and activation (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call